Emerald Health Therapeutics, Inc. (EMHTF) has an overall financial health rating of B+ with a composite score of 0 out of 5.
This suggests the company faces some financial challenges worth monitoring. Rating as of 2022-11-14.
| Date | Rating | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2022-11-14 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-11-11 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-11-10 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-11-09 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-11-08 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-11-07 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-11-04 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-11-03 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-11-02 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-11-01 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-10-31 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-10-28 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
